Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1830755

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1830755

Deoxyribonucleic Acid (DNA) Manufacturing Global Market Report 2025

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Deoxyribonucleic acid (DNA) manufacturing refers to the artificial creation or replication of DNA sequences using advanced biochemical techniques. This process involves synthesizing specific nucleotide sequences or amplifying existing DNA strands to generate large quantities of genetic material with high accuracy and purity.

The primary types of DNA manufacturing include plasmid DNA, synthetic DNA, gene synthesis, and oligonucleotide synthesis. Plasmid DNA is a small, circular, double-stranded DNA molecule that exists independently of a cell's chromosomal DNA. The products are available in multiple grades, including good manufacturing practices (GMP) grade and research and development grade, and are distributed for applications such as cell and gene therapy, vaccines, oligonucleotide-based drugs, and more. These services cater to end users including pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The deoxyribonucleic acid (DNA) manufacturing market research report is one of a series of new reports from The Business Research Company that provides deoxyribonucleic acid (DNA) manufacturing market statistics, including deoxyribonucleic acid (DNA) manufacturing industry global market size, regional shares, competitors with a deoxyribonucleic acid (DNA) manufacturing market share, deoxyribonucleic acid (DNA) manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the deoxyribonucleic acid (DNA) manufacturing industry. This deoxyribonucleic acid (DNA) manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deoxyribonucleic acid (DNA) manufacturing market size has grown rapidly in recent years. It will grow from $4.77 billion in 2024 to $5.58 billion in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth during the historic period can be attributed to the rise of genomics-based research, expansion of the biotechnology and biopharma sectors, increasing number of contract manufacturing organizations (CMOs), growth in CRISPR and gene-editing applications, and supportive government funding and initiatives.

The deoxyribonucleic acid (DNA) manufacturing market size is expected to see rapid growth in the next few years. It will grow to $10.28 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth during the forecast period can be attributed to the expansion of cell and gene therapy pipelines, increased drug discovery activities, rising biodefense initiatives, greater spending on pandemic preparedness, and the globalization of biomanufacturing supply chains. Key trends in this period include integration with next-generation sequencing (NGS), advancements in mRNA and DNA vaccines, improvements in long-read and high-fidelity DNA synthesis, increased use of automation and robotics in DNA manufacturing, and the development of next-generation enzymatic DNA synthesis (EDS).

The growing demand for gene therapies is expected to drive the expansion of the deoxyribonucleic acid (DNA) manufacturing market in the coming years. Gene therapies involve techniques that modify or replace defective genes to treat or prevent diseases, while personalized medicine focuses on tailoring medical treatments to an individual's genetic, biological, and lifestyle characteristics. The increasing demand for gene therapies is largely fueled by the rising prevalence of genetic disorders, including cystic fibrosis, sickle cell anemia, and certain inherited forms of blindness. DNA manufacturing supports gene therapies by supplying high-quality, custom DNA sequences required to develop and deliver therapeutic genes capable of correcting or replacing faulty genetic material in patients. For example, in August 2024, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the number of individuals eligible for gene therapy treatments in the UK is projected to increase from 2,500 in 2021 to as many as 10,000 annually by 2028. Consequently, the growing demand for gene therapies is driving the growth of the DNA manufacturing market.

Key players in the DNA manufacturing market are concentrating on innovative approaches, such as GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production involves manufacturing plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory standards ensuring the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell, offering in-house analytical testing, method development, and project management. The service provides unique advantages, including end-to-end process development, analytical testing, method optimization, and project oversight, eliminating the need for multiple suppliers and accelerating development timelines. It ensures high-quality output with >=85% supercoiled plasmid DNA content while minimizing contamination risks. ProBio also offers GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids within three months.

In December 2022, Polyplus-transfection S.A., a France-based biotechnology company, acquired Xpress Biologics S.A. for an undisclosed amount. Through this acquisition, Polyplus aims to expand its plasmid DNA and protein production capabilities to support advanced therapy applications, including gene therapy, mRNA, and viral vector manufacturing. Xpress Biologics S.A., based in Belgium, provides DNA manufacturing services.

Major players in the deoxyribonucleic acid (DNA) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in deoxyribonucleic acid (DNA) manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the deoxyribonucleic acid (DNA) manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The deoxyribonucleic acid (DNA) manufacturing market consists of sales of synthetic DNA, plasmid DNA, linear DNA, oligonucleotides, and gene constructs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deoxyribonucleic Acid (DNA) Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on deoxyribonucleic acid (dna) manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deoxyribonucleic acid (dna) manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deoxyribonucleic acid (dna) manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Plasmid Deoxyribonucleic Acid (DNA); Synthetic Deoxyribonucleic Acid (DNA); Gene Synthesis; Oligonucleotide Synthesis
  • 2) By Grade: Good Manufacturing Practices (GMP) Grade; Research And Development Grade
  • 3) By Application: Cell And Gene Therapy; Vaccines; Oligonucleotide-Based Drugs; Other Applications
  • 4) By End-Use: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations
  • Subsegments:
  • 1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA; Non-GMP-Grade Plasmid DNA; High Copy Number Plasmids; Low Copy Number Plasmids; Bacterial Fermentation-Based Plasmid Production; Transfection-Grade Plasmid DNA
  • 2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis; Chemical DNA Synthesis; Long DNA Fragments; Short DNA Fragments; Single-Stranded Synthetic DNA; Double-Stranded Synthetic DNA
  • 3) By Gene Synthesis: Custom Gene Synthesis; Standard Gene Synthesis; Complex Gene Constructs; Codon Optimization Services; Gene Library Synthesis
  • 4) By Oligonucleotide Synthesis: DNA Oligonucleotides; Modified Oligonucleotides; Long Oligonucleotides; PCR Primers; SiRNA And Antisense Oligos; Adapter And Linker Oligos
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Lonza Group AG; Kaneka Corporation; Catalent Inc.; Charles River Laboratories International Inc.; WuXi Biologics Inc.; AGC Biologics Inc.; Integrated DNA Technologies Inc.; GenScript Biotech Corporation; Takara Bio USA Inc.; Twist Bioscience Corp.; Ajinomoto Bio-Pharma Services; OriGene Technologies Inc.; DNA Script SAS; Eurofins Genomics LLC; Touchlight Genetics Ltd.; Elegen Inc.; VGXI Inc.; PlasmidFactory GmbH & Co. KG.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.
Product Code: r37743

Table of Contents

1. Executive Summary

2. Deoxyribonucleic Acid (DNA) Manufacturing Market Characteristics

3. Deoxyribonucleic Acid (DNA) Manufacturing Market Trends And Strategies

4. Deoxyribonucleic Acid (DNA) Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Deoxyribonucleic Acid (DNA) Manufacturing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Deoxyribonucleic Acid (DNA) Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Deoxyribonucleic Acid (DNA) Manufacturing Market Growth Rate Analysis
  • 5.4. Global Deoxyribonucleic Acid (DNA) Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Deoxyribonucleic Acid (DNA) Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Deoxyribonucleic Acid (DNA) Manufacturing Total Addressable Market (TAM)

6. Deoxyribonucleic Acid (DNA) Manufacturing Market Segmentation

  • 6.1. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasmid Deoxyribonucleic Acid (DNA)
  • Synthetic Deoxyribonucleic Acid (DNA)
  • Gene Synthesis
  • Oligonucleotide Synthesis
  • 6.2. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Good Manufacturing Practices (GMP) Grade
  • Research And Development Grade
  • 6.3. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell And Gene Therapy
  • Vaccines
  • Oligonucleotide-Based Drugs
  • Other Applications
  • 6.4. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Contract Research Organizations
  • 6.5. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Sub-Segmentation Of Plasmid Deoxyribonucleic Acid (DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • GMP-Grade Plasmid DNA
  • Non-GMP-Grade Plasmid DNA
  • High Copy Number Plasmids
  • Low Copy Number Plasmids
  • Bacterial Fermentation-Based Plasmid Production
  • Transfection-Grade Plasmid DNA
  • 6.6. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Sub-Segmentation Of Synthetic Deoxyribonucleic Acid (DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzymatic DNA Synthesis
  • Chemical DNA Synthesis
  • Long DNA Fragments
  • Short DNA Fragments
  • Single-Stranded Synthetic DNA
  • Double-Stranded Synthetic DNA
  • 6.7. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Sub-Segmentation Of Gene Synthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Custom Gene Synthesis
  • Standard Gene Synthesis
  • Complex Gene Constructs
  • Codon Optimization Services
  • Gene Library Synthesis
  • 6.8. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Sub-Segmentation Of Oligonucleotide Synthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA Oligonucleotides
  • Modified Oligonucleotides
  • Long Oligonucleotides
  • PCR Primers
  • SiRNA And Antisense Oligos
  • Adapter And Linker Oligos

7. Deoxyribonucleic Acid (DNA) Manufacturing Market Regional And Country Analysis

  • 7.1. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Deoxyribonucleic Acid (DNA) Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 8.1. Asia-Pacific Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 9.1. China Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 9.2. China Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 10.1. India Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 11.1. Japan Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 11.2. Japan Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 12.1. Australia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 13.1. Indonesia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 14.1. South Korea Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 14.2. South Korea Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 15.1. Western Europe Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 15.2. Western Europe Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 16.1. UK Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 17.1. Germany Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 18.1. France Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 19.1. Italy Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 20.1. Spain Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 21.1. Eastern Europe Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 21.2. Eastern Europe Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 22.1. Russia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 23.1. North America Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 23.2. North America Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 24.1. USA Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 24.2. USA Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 25.1. Canada Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 25.2. Canada Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 26.1. South America Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 26.2. South America Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 27.1. Brazil Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 28.1. Middle East Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 28.2. Middle East Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Deoxyribonucleic Acid (DNA) Manufacturing Market

  • 29.1. Africa Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
  • 29.2. Africa Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Deoxyribonucleic Acid (DNA) Manufacturing Market Competitive Landscape And Company Profiles

  • 30.1. Deoxyribonucleic Acid (DNA) Manufacturing Market Competitive Landscape
  • 30.2. Deoxyribonucleic Acid (DNA) Manufacturing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Kaneka Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Deoxyribonucleic Acid (DNA) Manufacturing Market Other Major And Innovative Companies

  • 31.1. Charles River Laboratories International Inc.
  • 31.2. WuXi Biologics Inc.
  • 31.3. AGC Biologics Inc.
  • 31.4. Integrated DNA Technologies Inc.
  • 31.5. GenScript Biotech Corporation
  • 31.6. Takara Bio USA Inc.
  • 31.7. Twist Bioscience Corp.
  • 31.8. Ajinomoto Bio-Pharma Services
  • 31.9. OriGene Technologies Inc.
  • 31.10. DNA Script SAS
  • 31.11. Eurofins Genomics LLC
  • 31.12. Touchlight Genetics Ltd.
  • 31.13. Elegen Inc.
  • 31.14. VGXI Inc.
  • 31.15. PlasmidFactory GmbH & Co. KG

32. Global Deoxyribonucleic Acid (DNA) Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Deoxyribonucleic Acid (DNA) Manufacturing Market

34. Recent Developments In The Deoxyribonucleic Acid (DNA) Manufacturing Market

35. Deoxyribonucleic Acid (DNA) Manufacturing Market High Potential Countries, Segments and Strategies

  • 35.1 Deoxyribonucleic Acid (DNA) Manufacturing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Deoxyribonucleic Acid (DNA) Manufacturing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Deoxyribonucleic Acid (DNA) Manufacturing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!